|

68Ga-DFC413 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Novartis Pharmaceuticals1

Indications

  • HR+/HER2- Lobular Breast Cancer (BC)1
  • HR+/HER2- Ductal Breast Cancer (BC)1
  • Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)1
  • Soft Tissue Sarcoma (STS)1
  • Triple Negative Breast Cancer (TNBC)1

Other1 trial

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.